RLMD
Investing in Relmada Therapeutics Inc (RLMD): What You Must Know
Relmada Therapeutics Inc’s recent filing unveils that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million ...
The Potential Rise in the Price of Relmada Therapeutics Inc (RLMD) following insiders activity
In a filing, Relmada Therapeutics Inc revealed its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million ...
Examining the Potential Price Growth of Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Inc’s filing revealed that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on ...
A Guide To The Risks Of Investing In Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Inc’s filing revealed that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on ...
RLMD shares expected to outperform in the next 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Mizuho upgrades Relmada Therapeutics Inc (RLMD) stock to an Outperform
Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million ...
RLMD’s latest rating updates from top analysts.
Relmada Therapeutics Inc’s recently made public that its Chief Financial Officer Shenouda Maged acquired Company’s shares for reported $1.1 million ...
